Biofrontera Inc.(BFRI)

Medical - Pharmaceuticals · Woburn, MA

$0.91+0.02 (+1.82%)

Delayed quote: Oct 6, 2026, 11:25 AM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T15:26:07.502Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:26:07.502Z.

Quote observation: 2026-10-06T15:25:20.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -3,685,000
Quote market capitalization: 11,613,914
Total debt · period ending 2026-06-30: 7,504,000
Cash · period ending 2026-06-30: 4,659,000

FMP input reference: b47096c20191003074eea3dc75a1498d2bed5743fa2797f84e024bc92f81a74c

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

BFRI EBITDA Yield Metrics

EBITDA YIELD

N/A

BFRI Competitors' EBITDA Yield

BFRI

Biofrontera Inc.

Current

Market Cap

$11.61M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ADIL

Adial Pharmaceuticals, Inc.

vs BFRI

Market Cap

$11.28M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KPRX

Kiora Pharmaceuticals, Inc.

vs BFRI

Market Cap

$11.30M

EBITDA Yield

N/A

TTM Avg

41.52%

3Y Avg

41.52%

5Y Avg

41.52%

BIVI

BioVie Inc.

vs BFRI

Market Cap

$11.20M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLUR

Pluri Inc.

vs BFRI

Market Cap

$11.17M

EBITDA Yield

N/A

TTM Avg

0.09%

3Y Avg

0.09%

5Y Avg

0.09%

GDTC

CytoMed Therapeutics Limited

vs BFRI

Market Cap

$10.94M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LSTA

Lisata Therapeutics, Inc.

vs BFRI

Market Cap

$10.93M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLRZ

Polyrizon Ltd.

vs BFRI

Market Cap

$10.81M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BFRG

Bullfrog AI Holdings, Inc. Common Stock

vs BFRI

Market Cap

$11.94M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNSY

Cerenome, Inc.

vs BFRI

Market Cap

$10.74M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Biofrontera Inc. (BFRI)	$11.61M	N/A	N/A	N/A	N/A
Adial Pharmaceuticals, Inc. (ADIL)vs ›	$11.28M	N/A	N/A	N/A	N/A
Kiora Pharmaceuticals, Inc. (KPRX)vs ›	$11.30M	N/A	41.52%	41.52%	41.52%
BioVie Inc. (BIVI)vs ›	$11.20M	N/A	N/A	N/A	N/A
Pluri Inc. (PLUR)vs ›	$11.17M	N/A	0.09%	0.09%	0.09%
CytoMed Therapeutics Limited (GDTC)vs ›	$10.94M	N/A	N/A	N/A	N/A
Lisata Therapeutics, Inc. (LSTA)vs ›	$10.93M	N/A	N/A	N/A	N/A
Polyrizon Ltd. (PLRZ)vs ›	$10.81M	N/A	N/A	N/A	N/A
Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs ›	$11.94M	N/A	N/A	N/A	N/A
Cerenome, Inc. (CNSY)vs ›	$10.74M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

BFRI EBITDA Yield Metrics

BFRI Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics